five

Dataset from A Randomized, Open-Label, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide in Subjects With Type 2 Diabetes Mellitus

收藏
NIAID Data Ecosystem2026-05-10 收录
下载链接:
https://doi.org/10.25934/00000927
下载链接
链接失效反馈
官方服务:
资源简介:
This open-label study examines the efficacy and safety of albiglutide as compared with liraglutide in subjects with type 2 diabetes.
创建时间:
2025-12-08
二维码
社区交流群
二维码
科研交流群
商业服务